
The Competition Commission of India (CCI) closed abuse of dominance proceedings against 12 super-speciality hospitals in Delhi-NCR accused of overcharging patients for room rent, medical tests, medicines, consumables, and medical devices.
The case originated from a 2015 complaint alleging inflated prices for disposable syringes at Max Super Specialty Hospital, Patparganj.
While the Director General had found possible violations between 2015 and 2018, the CCI disagreed and held that no contravention of Section 4 of the Competition Act was established.
The Commission observed that hospitals provide integrated healthcare services and cannot be assessed like standalone pharmacies, hotels, or diagnostic centres.
S PavithraBookmark